Literature DB >> 22249956

Injection drug use and HIV antiretroviral therapy discontinuation in a Canadian setting.

Dan Werb1, M-J Milloy, Thomas Kerr, Ruth Zhang, Julio Montaner, Evan Wood.   

Abstract

We investigated whether drug-related behaviors predicted antiretroviral therapy (ART) discontinuation among a cohort of injection drug users (IDU) in a Canadian setting. Cox regression analyses were used to investigate the impact of drug use patterns on rates of ART discontinuation among a sample of HIV-positive IDU in Vancouver, Canada between May 1996 and April 2008. In total, 408 HIV-positive IDU initiated ART during the study period, among whom 257 (63.0%) discontinued ART at least once. Rates of ART discontinuation were not significantly elevated among those who reported ongoing injection of heroin, cocaine, or other illicit drugs in comparison to those who reported not injecting drugs. However, public drug use was significantly predictive of ART discontinuation. Our findings may contribute to a reconsideration of the role of active drug use in determining retention in ART programs among IDU.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22249956      PMCID: PMC4931799          DOI: 10.1007/s10461-012-0136-y

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  26 in total

1.  Staging for antiretroviral therapy among HIV-infected drug users.

Authors:  Evan Wood; Robert S Hogg; Simon Bonner; Thomas Kerr; Kathy Li; Anita Palepu; Silvia Guillemi; Martin T Schechter; Julio S G Montaner
Journal:  JAMA       Date:  2004-09-08       Impact factor: 56.272

2.  Applied analysis of recurrent events: a practical overview.

Authors:  Jos W R Twisk; Nynke Smidt; Wieke de Vente
Journal:  J Epidemiol Community Health       Date:  2005-08       Impact factor: 3.710

3.  Determinants of HAART discontinuation among injection drug users.

Authors:  T Kerr; A Marshall; J Walsh; A Palepu; M Tyndall; J Montaner; R Hogg; E Wood
Journal:  AIDS Care       Date:  2005-07

4.  Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm.

Authors:  Tim Rhodes; Jo Kimber; Will Small; John Fitzgerald; Thomas Kerr; Matthew Hickman; Greg Holloway
Journal:  Addiction       Date:  2006-10       Impact factor: 6.526

5.  Public injecting among a cohort of injecting drug users in Vancouver, Canada.

Authors:  K DeBeck; W Small; E Wood; K Li; J Montaner; T Kerr
Journal:  J Epidemiol Community Health       Date:  2008-07-15       Impact factor: 3.710

6.  'Seek, test and treat' slows HIV.

Authors:  Erika Check Hayden
Journal:  Nature       Date:  2010-02-25       Impact factor: 49.962

7.  Enhanced HIV testing, treatment, and support for HIV-infected substance users.

Authors:  Nora D Volkow; Julio Montaner
Journal:  JAMA       Date:  2010-04-14       Impact factor: 56.272

8.  HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.

Authors:  Frederick L Altice; R Douglas Bruce; Gregory M Lucas; Paula J Lum; P Todd Korthuis; Timothy P Flanigan; Chinazo O Cunningham; Lynn E Sullivan; Pamela Vergara-Rodriguez; David A Fiellin; Adan Cajina; Michael Botsko; Vijay Nandi; Marc N Gourevitch; Ruth Finkelstein
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

9.  Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.

Authors:  Thomas Kerr; Anita Palepu; Gordon Barness; John Walsh; Robert Hogg; Julio Montaner; Mark Tyndall; Evan Wood
Journal:  Antivir Ther       Date:  2004-06

10.  Barriers to use of free antiretroviral therapy in injection drug users.

Authors:  S A Strathdee; A Palepu; P G Cornelisse; B Yip; M V O'Shaughnessy; J S Montaner; M T Schechter; R S Hogg
Journal:  JAMA       Date:  1998-08-12       Impact factor: 56.272

View more
  12 in total

1.  Antiretroviral Therapy Interruption Among HIV Postive People Who Use Drugs in a Setting with a Community-Wide HIV Treatment-as-Prevention Initiative.

Authors:  Ryan McNeil; Thomas Kerr; Bill Coleman; Lisa Maher; M J Milloy; Will Small
Journal:  AIDS Behav       Date:  2017-02

2.  Mortality and virological failure among HIV-infected people who inject drugs on antiretroviral treatment in China: An observational cohort study.

Authors:  Yan Zhao; Mingjie Zhang; Cynthia X Shi; Jie Huang; Fujie Zhang; Keming Rou; Zunyou Wu
Journal:  Drug Alcohol Depend       Date:  2016-11-19       Impact factor: 4.492

Review 3.  Adherence to antiretroviral medications among persons who inject drugs in transitional, low and middle income countries: an international systematic review.

Authors:  Jonathan Feelemyer; Don Des Jarlais; Kamyar Arasteh; Anneli Uusküla
Journal:  AIDS Behav       Date:  2015-04

4.  Comparative Clinical Outcomes With Scale-up of Dolutegravir as First-Line Antiretroviral Therapy in Ukraine.

Authors:  Kostyantyn Dumchev; Tetiana Kiriazova; Serhiy Riabokon; Alyona Shost; Canada Parrish; Anna Shapoval; Myroslava Germanovych; Jeremy Penner; Jason Beste; Nancy Puttkammer
Journal:  J Acquir Immune Defic Syndr       Date:  2022-10-01       Impact factor: 3.771

Review 5.  Challenges in managing HIV in people who use drugs.

Authors:  Adeeba Kamarulzaman; Frederick L Altice
Journal:  Curr Opin Infect Dis       Date:  2015-02       Impact factor: 4.915

6.  Temporal trends in the discontinuation of first-line antiretroviral therapy.

Authors:  Alejandro Gonzalez-Serna; Keith Chan; Benita Yip; William Chau; Rachel McGovern; Hasina Samji; Viviane Dias Lima; Robert S Hogg; Richard Harrigan
Journal:  J Antimicrob Chemother       Date:  2014-04-15       Impact factor: 5.790

Review 7.  Public health and international drug policy.

Authors:  Joanne Csete; Adeeba Kamarulzaman; Michel Kazatchkine; Frederick Altice; Marek Balicki; Julia Buxton; Javier Cepeda; Megan Comfort; Eric Goosby; João Goulão; Carl Hart; Thomas Kerr; Alejandro Madrazo Lajous; Stephen Lewis; Natasha Martin; Daniel Mejía; Adriana Camacho; David Mathieson; Isidore Obot; Adeolu Ogunrombi; Susan Sherman; Jack Stone; Nandini Vallath; Peter Vickerman; Tomáš Zábranský; Chris Beyrer
Journal:  Lancet       Date:  2016-03-24       Impact factor: 79.321

8.  Antiretroviral Therapy (ART) Use, Human Immunodeficiency Virus (HIV)-1 RNA Suppression, and Medical Causes of Hospitalization Among HIV-Infected Intravenous Drug Users in the Late ART Era.

Authors:  Gabriel Vallecillo; Sergio Mojal; Marta Torrens; Roberto Muga
Journal:  Open Forum Infect Dis       Date:  2014-06-19       Impact factor: 3.835

9.  Physicians' patient base composition and mortality among people living with HIV who initiated antiretroviral therapy in a universal care setting.

Authors:  Beverly Allan; Kalysha Closson; Alexandra B Collins; Mia Kibel; Shenyi Pan; Zishan Cui; Taylor McLinden; Surita Parashar; Viviane Dias Lima; Jason Chia; Benita Yip; Rolando Barrios; Julio S G Montaner; Robert S Hogg
Journal:  BMJ Open       Date:  2019-03-20       Impact factor: 2.692

10.  Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and drug treatment initiation and engagement among people living with the human immunodeficiency virus (HIV) and patients without an HIV diagnosis.

Authors:  Rulin C Hechter; Michael A Horberg; Constance Weisner; Cynthia I Campbell; Richard Contreras; Lie-Hong Chen; Bobbi Jo H Yarborough; Gwen T Lapham; Irina V Haller; Brian K Ahmedani; Ingrid A Binswanger; Andrea H Kline-Simon; Derek D Satre
Journal:  Subst Abus       Date:  2019-03-25       Impact factor: 3.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.